Company / Current Assets
West Pharmaceutical Services Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$2.0B
FY2025
5-year range
$1.5B / $2.0B
FY2021-FY2025
Trend
+28.6%
vs FY2024
Sector context
#51 of 160
Health Care
What the data says
At $2.0B, West Pharmaceutical Services's current assets ranks #51 of 160 in the Health Care sector. Improved from $1.9B to $2.0B over the past 2 years.
Based on SEC 10-K filings.
$2.0B in FY2025 with a 5-year CAGR of +7.6%.
Improved from $1.9B to $2.0B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +1.0%
- 5-Year CAGR
- +7.6%
- 10-Year CAGR
- -
Sector benchmark
#51 of 160 in Health CareTop 32% of 160This company $2.0B Sector average $5.2B
▼
-62.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +7.6%, indicating consistent growth.
- In FY2025, current assets increased 28.6% year-over-year.
- Ranks #51 out of 160 companies in the Health Care sector.
- Lowest current assets in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.0B | +28.6% |
| FY2024 | $1.5B | -20.6% |
| FY2023 | $1.9B | +0.9% |
| FY2022 | $1.9B | +10.2% |
| FY2021 | $1.7B | +26.8% |
| FY2020 | $1.4B | +29.8% |
| FY2019 | $1.1B | +18.4% |
| FY2018 | $894.4M | +20.3% |
| FY2017 | $743.5M | +15.8% |
| FY2016 | $641.9M | -4.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026